Medicare Enrolled
Dr. Ali Valika, MD
Cardiovascular Disease · Elmhurst, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Valika from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Valika?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Valika
Dr. Ali Valika is a cardiovascular disease specialist in Elmhurst, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Valika performed 2,168 Medicare services across 1,398 unique beneficiaries.
Between the years covered by Open Payments, Dr. Valika received a total of $196,258 from 36 pharmaceutical and/or device companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Valika is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 45% volume in IL
$196,258 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,168
Medicare services
Top 45% in IL for cardiovascular disease
1,398
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~114 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
396 | $133 | $366 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
291 | $92 | $248 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
165 | $96 | $259 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
155 | $145 | $822 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
148 | $63 | $168 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
136 | $45 | $92 |
| Remote monitoring of pulmonary artery pressure sensor This procedure involves the remote tracking of pressure readings from a sensor in the pulmonary artery over a period of up to 30 days. |
111 | $40 | $113 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
107 | $136 | $437 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
89 | $376 | $600 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
84 | $166 | $678 |
| 3D radiographic procedure A radiographic imaging technique that creates three-dimensional representations of internal structures. |
69 | $19 | $170 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
65 | $8 | $22 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
44 | $359 | $1,607 |
| Heart muscle strain imaging | 44 | $30 | $86 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
43 | $51 | $343 |
| Exercise stress test A test that monitors the heart and lungs while the patient exercises to evaluate their function under physical stress. |
37 | $117 | $543 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
34 | $6 | $31 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
34 | $31 | $106 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
31 | $10 | $163 |
| Right heart catheterization A procedure where a thin, flexible tube is inserted into the right side of the heart to measure pressure and oxygen levels. |
30 | $102 | $555 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
23 | $28 | $73 |
| New patient office visit, complex (60-74 min) | 21 | $174 | $458 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
11 | $12 | $82 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.5% high complexity
20.8% medium
70.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$196,258
Total received (2018-2024)
Avg $28,037/year across 7 years
Top 2% in IL for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
490
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$147,654 (75.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$39,795 (20.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,809 (4.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$20,309
2023
$38,706
2022
$31,094
2021
$26,371
2020
$19,317
2019
$30,468
2018
$29,992
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$9,594
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,574
Lilly USA, LLC
$4,420
ABIOMED
$363
Abbott Laboratories
$304
Ancora Heart, Inc.
$260
Cardiac Dimensions, Inc.
$249
Novo Nordisk Inc
$226
Amgen Inc.
$142
Boston Scientific Corporation
$98
Actelion Pharmaceuticals US, Inc.
$36
PFIZER INC.
$24
CORDIS US CORP.
$19
Top 3 companies account for 91.5% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$43,935
E.R. Squibb & Sons, L.L.C.
$32,405
Abbott Laboratories
$31,428
Novartis Pharmaceuticals Corporation
$29,307
PFIZER INC.
$14,957
AstraZeneca Pharmaceuticals LP
$12,384
Lilly USA, LLC
$10,812
Actelion Pharmaceuticals US, Inc.
$5,096
SCPHARMACEUTICALS INC.
$4,271
Alnylam Pharmaceuticals Inc.
$3,630
Ancora Heart, Inc.
$3,191
ABIOMED
$819
Medtronic Vascular, Inc.
$597
Cardiac Dimensions, Inc.
$491
Novo Nordisk Inc
$490
W. L. Gore & Associates, Inc.
$350
Boston Scientific Corporation
$228
Nuwellis, Inc.
$217
Amgen Inc.
$206
Janssen Pharmaceuticals, Inc
$170
Edwards Lifesciences Corporation
$165
CVRx, Inc.
$163
Itamar Medical Inc
$138
ZOLL Respicardia, Inc.
$115
LivaNova USA, Inc.
$100
ENDOTRONIX, INC.
$99
La Jolla Pharmaceutical Company
$98
Philips Electronics North America Corporation
$95
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$59
Terumo Medical Corporation
$54
Janssen Scientific Affairs, LLC
$50
GlaxoSmithKline, LLC.
$46
SANOFI-AVENTIS U.S. LLC
$26
United Therapeutics Corporation
$26
Medtronic, Inc.
$21
CORDIS US CORP.
$19
Top 3 companies account for 54.9% of all-time payments
Associated products mentioned in payments ›
(4066) Tack Endo Sys ATK · (6571) Eagle Eye · AQUADEX SMARTFLOW CONSOLE · AccuCinch · AngioSeal · Aquadex Smartflow Console · BENLYSTA · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CORDELLA PULOMONARY ARTERY PRESSURE SENSOR · CardioMEMS HF System · CoreValve Evolut · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · FARXIGA · FUROSCIX · GIAPREZA · HeartMate · HeartMate 3 Left Ventricular Dev · HeartMate Touch · HeartWare HVAD · INVOKANA · Impella · JARDIANCE · LINQ II · LifeVest · METACROSS OTW · MITRACLIP · MULTAQ · MYNXGRIP · Mitra Clip system · MitraClip System · ONPATTRO · OPSUMIT MACITENTAN · Ozempic · PRADAXA · PRALUENT · Pacemakers · Product in Development · Repatha · SAPIEN 3 Ultra RESILIA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TandemLife · UPTRAVI · VYNDAQEL · WATCHMAN · WATCHMAN Access System · WatchPAT · Wegovy · XARELTO · Xience Sierra Coronary Stent System · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (75%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for cardiovascular disease in IL.
Geographic Context
Cardiologists within 10 mi
666
Per 100K population
71.8
County median income
$110,502
Nearest hospital
ELMHURST MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Valika is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of IL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Valika experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Valika performed 396 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Valika receive payments from pharmaceutical companies?
Yes. Dr. Valika received a total of $196,258 from 36 companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Valika's costs compare to other cardiologists in Elmhurst?
Dr. Valika's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Valika) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Elmhurst
Browse cardiologists in Elmhurst ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in IL
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in IL
Which IL cardiologists receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology